The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in low viral-load samples
Read MoreIn this partnership, Lumiii will apply UCL EdTech Labs' research-focused method, expert mentoring, and community knowledge to its storytelling.
Read More